SCHWARZEROVÁ, Jana, Martin HURTA, Vojtěch BARTOŇ, Matej LEXA, Dirk WALTHER, Valentine PROVAZNÍK a Wolfram WECKWERTH. A perspective on genetic and polygenic risk scores — advances and limitations and overview of associated tools. Briefings in Bioinformatics. Oxford University Press, 2024, roč. 25, č. 3, s. bbae240, 11 s. ISSN 1467-5463. Dostupné z: https://dx.doi.org/10.1093/bib/bbae240.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název A perspective on genetic and polygenic risk scores — advances and limitations and overview of associated tools
Autoři SCHWARZEROVÁ, Jana, Martin HURTA, Vojtěch BARTOŇ, Matej LEXA, Dirk WALTHER, Valentine PROVAZNÍK a Wolfram WECKWERTH.
Vydání Briefings in Bioinformatics, Oxford University Press, 2024, 1467-5463.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 9.500 v roce 2022
Organizační jednotka Fakulta informatiky
Doi http://dx.doi.org/10.1093/bib/bbae240
Klíčová slova anglicky polygenic risk score; genetic variations; GWAS; genomic prediction; genotype; phenotype
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnil: doc. Ing. Matej Lexa, Ph.D., učo 31298. Změněno: 22. 5. 2024 09:19.
Anotace
Polygenetic Risk Scores are used to evaluate an individual's vulnerability to developing specific diseases or conditions based on their genetic composition, by taking into account numerous genetic variations. This article provides an overview of the concept of Polygenic Risk Scores (PRS). We elucidate the historical advancements of PRS, their advantages and shortcomings in comparison with other predictive methods, and discuss their conceptual limitations in light of the complexity of biological systems. Furthermore, we provide a survey of published tools for computing PRS and associated resources. The various tools and software packages are categorized based on their technical utility for users or prospective developers. Understanding the array of available tools and their limitations is crucial for accurately assessing and predicting disease risks, facilitating early interventions, and guiding personalized healthcare decisions. Additionally, we also identify potential new avenues for future bioinformatic analyzes and advancements related to PRS.
VytisknoutZobrazeno: 18. 7. 2024 18:14